Fiasp 100IU/ml Penfill (3ml Each) contains Insulin Aspart, a rapid-acting insulin analog used to improve glycemic control in individuals with diabetes mellitus. Each Penfill cartridge delivers 100 units of insulin aspart per milliliter, designed for use with compatible insulin pens to facilitate precise dosing. Insulin Aspart works by mimicking the natural insulin produced by the pancreas, promoting the uptake of glucose into muscle and fat cells, thereby lowering blood glucose levels. Fiasp is characterized by its ultra-fast onset of action, typically beginning to work within minutes after injection, making it particularly effective for controlling postprandial blood sugar spikes. This rapid activity allows for more flexible dosing around meal times compared to regular insulin. Fiasp is indicated for adults and children with type 1 and type 2 diabetes who require insulin therapy to achieve optimal blood sugar management. It should be administered subcutaneously, usually within 0 to 2 minutes before starting a meal or up to 20 minutes after starting a meal if necessary. Proper storage and handling are essential to maintain insulin potency. Patients should follow their healthcare provider’s instructions regarding dosage and administration to minimize the risk of hypoglycemia and other adverse effects.